Celsius Holdings, Inc. Common Stock
CELH
$27.86
-5.91%
Celsius Holdings operates in the energy drink subsegment of the global non-alcoholic beverage market, owning and marketing brands including Celsius, Alani Nu, and Rockstar Energy. The company is a high-growth disruptor in the functional beverage space, leveraging a capital-light model that outsources manufacturing and relies on a strategic distribution partnership with PepsiCo. The current investor narrative is dominated by the company's transformation into a multi-brand platform following the Alani Nu acquisition, which is seen as crucial for sustaining growth amidst intense competition, while recent stock volatility reflects debates over valuation and execution risk in a maturing market.…
CELH
Celsius Holdings, Inc. Common Stock
$27.86
Related headlines
Investment Opinion: Should I buy CELH Today?
Rating: Hold. The core thesis is that CELH is a high-risk, high-potential turnaround story caught between deteriorating near-term fundamentals and a compelling long-term strategic position, making it unsuitable for new capital until execution improves.
Supporting evidence includes a reasonable forward P/E of 16.6x based on analyst EPS estimates of $2.67, which implies significant earnings growth. However, this is contradicted by a trailing P/E of 99.6x and volatile quarterly profits. Revenue growth, while appearing strong at 117.2% YoY in Q4, is inflated by acquisition and shows sequential stagnation. The balance sheet is a relative strength with a debt-to-equity of 0.23, but this is offset by the alarming -$130.0 million quarterly free cash flow. Analyst sentiment is bullish on average, but the limited coverage (5 analysts) and wide EPS estimate range ($2.47 to $2.89) reflect high uncertainty.
The two biggest risks are sustained negative free cash flow and a failure to achieve the earnings implied by the forward multiple. This Hold would upgrade to a Buy if the company demonstrates two consecutive quarters of positive and growing operating cash flow alongside gross margin stabilization above 48%. It would downgrade to a Sell if quarterly revenue declines sequentially or if the forward P/E expands above 25x without corresponding earnings growth. Relative to its own history and the growth expectations embedded in its price, the stock is fairly valued for the high risk it presents, but it is not clearly undervalued given the operational challenges.
Sign up to view all
CELH 12-Month Price Forecast
CELH is a binary bet on execution at a critical juncture. The strategic assets—PepsiCo partnership and multi-brand portfolio—are valuable, but the financials are currently too volatile to justify a bullish stance. The neutral view is based on the high probability (50%) base case of messy, volatile progress. The stance would upgrade to bullish on concrete evidence of margin stabilization and consistent cash generation for two quarters. It would turn bearish on a breakdown of the $32 support level or another quarter of severe cash burn. The wide target ranges reflect the high uncertainty inherent in the story.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Celsius Holdings, Inc. Common Stock's 12-month outlook, with a consensus price target around $36.22 and implied upside of +30.0% versus the current price.
Average Target
$36.22
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$22 - $36
Analyst target range
Analyst coverage is limited, with only 5 analysts providing estimates, which is typical for a mid-cap growth stock and can lead to higher volatility and less efficient price discovery. The consensus is implicitly bullish, with all recent institutional actions being Buys or Overweight ratings (e.g., Deutsche Bank upgrade to Buy, JP Morgan Overweight), and no Sell ratings aside from a maintained Underperform from B of A Securities; the average revenue estimate for the next period is $4.56 billion, implying significant growth from current levels. The target price range is not explicitly provided in the data, but the wide dispersion in EPS estimates—with a low of $2.47 and a high of $2.89—signals some uncertainty around the precise earnings trajectory, though the overall direction is positive; the high estimates likely assume successful execution on the multi-brand strategy and margin improvement, while the low estimates may factor in continued competitive and integration challenges.
Bulls vs Bears: CELH Investment Factors
The evidence currently tilts bearish, as the bear points are grounded in concrete, recent financial deterioration (volatile earnings, cash burn, plateauing growth) while the bull case is largely predicated on future execution and valuation normalization. The single most important tension in the investment debate is the chasm between the company's current volatile, cash-burning reality and the smooth, high-growth earnings trajectory priced into its forward P/E of 16.6x. The thesis hinges entirely on whether the multi-brand strategy can quickly stabilize margins and generate consistent cash flow to justify the forward multiple, or if competitive and integration challenges will lead to further earnings disappointments and multiple compression.
Bullish
- Strong Strategic Partnership: The distribution and equity partnership with PepsiCo provides a significant competitive moat and a capital-light model for scaling. This relationship is critical for accessing mainstream retail channels and defending against larger competitors.
- Multi-Brand Platform Strategy: The acquisition of Alani Nu has successfully transformed Celsius into a multi-brand platform, driving record Q4 2025 revenue of $721.6 million, a 117.2% YoY increase. This diversification is key to sustaining growth as the core brand matures.
- Attractive Forward Valuation: The stock's forward P/E of 16.6x, based on analyst EPS estimates averaging $2.67, is reasonable for a high-growth consumer company. This represents a significant discount to the trailing P/E of 99.6x, implying the market expects strong earnings recovery.
- Deeply Oversold Technicals: Trading at $33.73, the stock is only 3% above its 52-week low of $32.01, having declined 44% over six months. This deep oversold condition, with a relative strength of -49.66 vs. the S&P 500, suggests most negative sentiment is priced in, creating a potential value opportunity.
Bearish
- Severe Growth Deceleration: Core brand growth has plateaued, with revenue stagnating in the $720-$740 million range for Q2-Q4 2025. The 117.2% YoY growth in Q4 is inflated by the Alani Nu acquisition, masking a maturing top-line trajectory.
- Extreme Earnings Volatility: Profitability is highly inconsistent, swinging from a net loss of -$61.0 million in Q3 2025 to net income of $24.7 million in Q4 2025. This volatility, coupled with a gross margin decline from 51.34% to 47.37% in the same period, signals execution and integration risks.
- Unsustainable Cash Burn: Q4 2025 operating cash flow was a significant outflow of -$119.4 million, leading to negative free cash flow of -$130.0 million for the quarter. This raises red flags about cash generation sustainability despite a positive trailing twelve-month FCF of $323.4 million.
- Stretched Trailing Valuation: The trailing P/E of 99.6x is extremely elevated, even if below its own recent peak of 108.7x. This valuation demands flawless execution on future earnings growth and leaves no room for error, making the stock vulnerable to multiple compression.
CELH Technical Analysis
The stock is in a pronounced downtrend, having declined 43.998% over the past six months and 3.27% over the past year, significantly underperforming the S&P 500's 29.04% gain. With a current price of $33.73, the stock is trading near the bottom of its 52-week range, at approximately 3% above its 52-week low of $32.01, indicating it is in deep oversold territory and may represent a potential value opportunity, though it carries significant 'falling knife' risk. Recent momentum shows continued weakness, with the stock down 35.73% over the last three months and a further 1.75% over the past month, suggesting the downtrend is persistent and not yet showing signs of a meaningful reversal. The stock's beta of 1.123 indicates it is moderately more volatile than the broader market, which has amplified its downside during this sell-off. Key technical support is firmly established at the 52-week low of $32.01, while resistance lies far above at the 52-week high of $66.74; a decisive break below the $32 support could trigger another leg down, whereas a recovery above the $40 level would be the first sign of stabilization. The stock's relative strength versus the S&P 500 is deeply negative across all measured periods, most notably at -49.66 over six months, underscoring its severe underperformance and lack of positive catalysts.
Beta
0.51
0.51x market volatility
Max Drawdown
-57.0%
Largest decline past year
52-Week Range
$28-$67
Price range past year
Annual Return
-26.5%
Cumulative gain past year
| Period | CELH Return | S&P 500 |
|---|---|---|
| 1m | -17.2% | +8.2% |
| 3m | -37.2% | +9.0% |
| 6m | -34.9% | +10.5% |
| 1y | -26.5% | +26.5% |
| ytd | -41.7% | +8.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CELH Fundamental Analysis
Revenue growth has decelerated significantly, with Q4 2025 revenue of $721.6 million representing a 117.2% year-over-year increase, a figure that is inflated by the inclusion of the Alani Nu acquisition; the sequential trend from Q2 and Q3 2025 shows revenue has plateaued around the $720-$740 million range, indicating core brand growth may be maturing. Profitability is inconsistent, as evidenced by a net income of $24.7 million in Q4 2025 following a substantial net loss of -$61.0 million in Q3 2025, while the gross margin of 47.37% in Q4 is healthy for the beverage industry but down from 51.34% in Q3, suggesting potential margin pressure from mix or competition. The company's balance sheet and cash flow show a mixed picture: it holds a solid current ratio of 1.68 and a manageable debt-to-equity ratio of 0.23, but Q4 2025 operating cash flow was a significant outflow of -$119.4 million, contributing to negative free cash flow of -$130.0 million for the quarter, raising questions about cash generation sustainability despite a positive trailing twelve-month free cash flow figure of $323.4 million.
Quarterly Revenue
$721628000.0B
2025-12
Revenue YoY Growth
+1.17%
YoY Comparison
Gross Margin
+0.47%
Latest Quarter
Free Cash Flow
$323375000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CELH Overvalued?
Given the company's positive but volatile net income, the primary valuation metric selected is the Price-to-Earnings (P/E) ratio. The trailing P/E is extremely elevated at 99.6x, while the forward P/E based on analyst estimates is a much lower 16.6x; this massive gap implies the market is pricing in a substantial recovery in earnings over the next year, contingent on the successful integration of acquisitions and margin expansion. Compared to sector averages (data not provided for direct comparison), the trailing P/E appears stretched, though the forward multiple suggests a more reasonable valuation if growth expectations are met; the stock's Price-to-Sales ratio of 4.28 and EV/Sales of 4.25 provide alternative checks given the earnings volatility. Historically, the stock's own valuation has compressed dramatically from recent highs; for instance, its P/E ratio at the end of Q1 2025 was 47.2x, and it has traded as high as 108.7x in Q4 2025, meaning the current 99.6x P/E, while high, is below its own recent peak but still reflects significant optimism embedded in the price.
PE
99.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -179x~1784x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
54.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced. The company exhibits severe earnings volatility, with a net loss of -$61.0 million in Q3 2025 followed by net income of $24.7 million in Q4 2025, making future profitability highly unpredictable. Cash flow sustainability is a major concern, as Q4 2025 saw a -$130.0 million free cash flow outflow despite positive TTM figures, indicating potential working capital or investment strains. Furthermore, revenue growth has plateaued sequentially around $720-$740 million, suggesting the core brand is maturing and future growth is dependent on the successful integration of Alani Nu, which carries significant execution risk.
Market & Competitive Risks are elevated. The stock's trailing P/E of 99.6x, though down from its peak, remains stretched and leaves it vulnerable to severe multiple compression if growth expectations are not met. With a beta of 1.123, the stock's volatility has amplified its 44% six-month decline during a market uptrend, indicating high sensitivity to growth stock sentiment shifts. The competitive landscape is intensifying, as noted in recent news, with pressure from retail giants like Costco threatening margins and market share in the concentrated North American market, which accounts for 95% of revenue.
Worst-Case Scenario involves a failure to integrate acquisitions and stabilize profitability, leading to consecutive earnings misses. This could trigger a loss of analyst confidence, a re-rating of the forward multiple closer to sector averages for stagnant growth, and a technical breakdown below the $32.01 support. In this adverse scenario, the stock could realistically revisit its 52-week low and potentially test levels 35-40% below the current price, representing a loss of approximately -$12 to -$14 per share from $33.73. The chain of events would be: Q2 2026 earnings miss on both revenue and margins, guidance reduction, analyst downgrades, and a breach of the $32 support triggering algorithmic and stop-loss selling.
FAQ
The key risks are, in order of severity: 1) Financial Execution Risk: Extreme quarterly earnings and cash flow volatility, exemplified by a -$130.0M FCF in Q4 2025. 2) Integration Risk: Failure to successfully integrate the Alani Nu acquisition and realize expected synergies. 3) Competitive Risk: Intense pressure from larger players like Costco in a concentrated North American market. 4) Valuation Risk: The high trailing P/E of 99.6x makes the stock vulnerable to severe multiple compression if growth expectations are downgraded, which could occur if any of the first three risks materialize.
The 12-month forecast is highly bifurcated. The base case (50% probability) sees the stock trading between $40 and $50 as it shows messy progress, aligning with analyst expectations for ~$4.56B in revenue. The bull case (25%) projects a rally to $55-$66 on successful execution and margin expansion. The bear case (25%) warns of a drop to $28-$32 if integration fails and cash burn continues. The most likely scenario is the base case, which assumes the company meets, but does not exceed, current lowered expectations, leading to range-bound trading.
CELH sends mixed valuation signals. It is dramatically overvalued on a trailing basis with a P/E of 99.6x, reflecting past hyper-growth. However, it appears potentially undervalued on a forward basis with a P/E of 16.6x, if analysts are correct about a surge in EPS to $2.67. The Price-to-Sales ratio of 4.28 is high for the beverage sector, indicating the market still prices in premium growth. Overall, the stock is fairly valued for the immense execution risk it carries; the market is paying a fair price for a risky turnaround story, not a discount for a stable grower.
CELH is not a good buy for most investors at this moment due to its high risk profile. While the forward P/E of 16.6x appears reasonable, it is predicated on flawless execution following a period of severe earnings volatility and cash burn. The stock is only suitable for highly risk-tolerant investors who believe the multi-brand strategy will quickly stabilize financials. For others, it is a 'watchlist' stock until the company proves it can generate consistent cash flow and meet analyst expectations.
CELH is strictly a long-term investment for those willing to hold for 3-5 years. Its high beta of 1.123 and recent 44% six-month decline make it far too volatile for short-term trading. The investment thesis revolves around the multi-year execution of a multi-brand platform strategy with PepsiCo, which will take several quarters to prove out. There is no dividend to support income investors. The minimum suggested holding period is 18-24 months to weather the inevitable quarterly volatility and assess whether the strategic plan is working.